Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor

OncoAlert and ecancer weekly roundup for November 2 - 7, 2020

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients

Critical issues in drug and biomarker development

OncoAlert and ecancer weekly roundup for October 26 - 31, 2020

OncoAlert and ecancer weekly roundup for October 19-26, 2020

OncoAlert and ecancer weekly roundup for October 12 - 18, 2020

Why don’t all European breast cancer patients get the most appropriate care?

Synchronous invasive ductal carcinoma of the breast and clear cell renal carcinoma with rare presentation and behaviour

Actionable pathogenic variant detection in breast cancer genes

MINDACT: 70-gene signature test as guidance for breast cancer treatment

OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer